Ypsomed Holding AG operates within the Surgical and medical instruments sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Ypsomed Holding AG with three other
medical equipment manufacturers in Europe:
sales of 2.08 billion Danish Kroner [US$313.33 million]
of which 61%
Orthofix International NV
of the Netherlands
(371.28 million Euro [US$415.30 million]
of which 43%
was BioStim), and
Consort Medical Plc
based in the United Kingdom
(£276.91 million [US$360.56 million]
of which 58%
During the year ended March of 2016, sales at
Ypsomed Holding AG were 336.92 million Swiss Francs (US$345.56 million).
increase of 9.9%
versus 2015, when the company's sales were 306.63 million Swiss Francs.
This was the third consecutive year of growth at Ypsomed Holding AG.
Sales of Delivery Devices saw an increase
11.3% in 2016, from
151.74 million Swiss Francs to 168.89 million Swiss Francs.
Not all segments of Ypsomed Holding AG experienced an increase in sales in 2016:
sales of Other Products fell 5.8% to 16.23 million Swiss Francs.